QED Clinical Services establishes subsidiary in India

Thursday, March 22, 2012 02:51 PM

CRO QED Clinical Services has created a wholly owned subsidiary, QED Clinical Services India Private Limited, in Ahmedabad, India, to enhance its global delivery of clinical trials.

The subsidiary adds operational and therapeutic expertise to QED, and expands its capacity and capability to offer more global coverage.

QED operations in India will be spearheaded by country head and director of operations Ali Saijad Bohra, who has led clinical monitoring, FSP models and project management across India, South East Asia, Japan, South Korea and Australia. 

“India and the Asia Pacific region will continue to have focus and will remain key markets for the drug development activities for biopharmaceutical companies on account of a variety of benefits,” said Bohra.

In addition to conducting trials in India, QED India will act as a hub for QED’s Asia Pacific operations for control and oversight of its local partners across the region.

“The creation of QED Clinical, India means that we can better meet the global development needs of our sponsors by giving access to vast patient populations via regional experts on the ground,” said CEO Thomas Ogorka. “India continues to receive great focus as an emerging territory and QED’s presence here means we can leverage its high-quality capabilities.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs